GL1X · GenesisL1 explorer

Research workbench

Optimization of orally bioavailable alkyl amine renin inhibitors

Analyse Optimization of orally bioavailable alkyl amine renin inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3KM4
Type
protein
Length
670 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
22X, NAG
Pockets
3 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33715% helix, 46% strandP00797
BRenin (EC 3.4.23.15)protein33316% helix, 46% strandP00797

Ligands and binding sites

  • 22X · (3R)-3-[(1S)-4-(acetylamino)-1-(3-chlorophenyl)-1-hydroxybutyl]-N-{(1S)-2-cyclohexyl-1-[(methylamino)methyl]ethyl}piperidine-1-carboxamide · ligand · 4 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110730.860.8710522X
2760.510.8420empty
3630.300.7418empty

Interfaces

1 interface between chains.

  • A–B · 1037 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 3KM4 · Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.